Cargando...
Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment
Vascular-targeted photodynamic therapy (VTP) using padeliporfin is currently assessed as a low-risk prostate cancer (LRPCa) treatment. The aim of this study was to assess erectile function outcomes of VTP for LRPCa treatment. We prospectively included all patients treated with VTP for LRPCa. The pri...
Gardado en:
| Publicado en: | Asian J Androl |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7523613/ https://ncbi.nlm.nih.gov/pubmed/31939351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aja.aja_138_19 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|